If you get a cut, break a bone or scrape an elbow, your bloodstream brings the injury all the necessary nutrients for healing. But if your cartilage gets damaged, you’re out of luck. This flexible soft tissue that cushions joints – especially in the knee – has no blood vessels and therefore little ability to heal itself.
However, a privately held Israeli medical device company is now offering a safe and effective, novel off-the-shelf cartilage regeneration solution in a global market worth an estimated $1.6 billion annually.
CartiHeal’s trademarked Agili-C can be implanted in a single-step arthroscopic procedure. In clinical studies, it was shown to regenerate true hyaline cartilage (the most abundant type of cartilage in the human body) after six months.
Founder and CEO Nir Altschuler tells ISRAEL 21c that this is a breakthrough in the field — the “Holy Grail” in orthopedics — because other experimental treatments generate only “hyaline-like” cartilage, which is actually a non-lasting fibrous tissue rather than the real deal.
More...